Chen Ni Selected Research

DH332

1/2014

DH332, a synthetic β-carboline alkaloid, inhibits B cell lymphoma growth by activation of the caspase family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chen Ni Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2013
6	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2014
5	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2013
4	Asthma (Bronchial Asthma) 01/2022 - 09/2012
2	Lymphoma (Lymphomas) 01/2022 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2015
2	Cardiotoxicity 10/2020 - 01/2019
1	Trigeminal Neuralgia (Tic Douloureux) 10/2022
1	Nervous System Diseases (Neurological Disorders) 10/2022
1	Parkinson Disease (Parkinson's Disease) 06/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2021
1	Colitis 04/2021
1	Ulcerative Colitis 04/2021
1	Burns 01/2021
1	Conversion Disorder (Astasia Abasia) 01/2021
1	Carcinoma (Carcinomatosis) 07/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Necrosis 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Encephalitis (Encephalitis, Rasmussen) 12/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2014
1	Triple Negative Breast Neoplasms 02/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Allergic Rhinitis 05/2013
1	Atopic Dermatitis (Atopic Eczema) 05/2013
1	Hypersensitivity (Allergy) 05/2013
1	Papilloma (Papillomatosis) 03/2013
1	Inflammation (Inflammations) 03/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2013

Drug/Important Bio-Agent (IBA)

4	InterferonsIBA 10/2020 - 12/2014
4	CytokinesIBA 07/2019 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 01/2019
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2019 - 01/2019
2	Peptides (Polypeptides)IBA 09/2019 - 01/2019
2	AngiopoietinsIBA 09/2019 - 01/2019
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2018
1	AntioxidantsIBA 10/2022
1	Uric Acid (Urate)IBA 10/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	OvalbuminIBA 01/2022
1	Tight Junction ProteinsIBA 01/2022
1	Dextran SulfateIBA 04/2021
1	coptisineIBA 04/2021
1	Therapeutic UsesIBA 04/2021
1	polydopamineIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2020
1	pembrolizumabIBA 07/2020
1	130-nm albumin-bound paclitaxelIBA 07/2020
1	CollagenIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2019
1	Interleukin-17 (Interleukin 17)IBA 07/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	asparaginylendopeptidase (legumain)IBA 01/2019
1	matrigelIBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2018
1	AntigensIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	TensinsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	Gemcitabine FDA Link 06/2016
1	Bevacizumab (Avastin)FDA Link 01/2015
1	Fenofibrate (CiL)FDA LinkGeneric 02/2014
1	Carbolines (Beta-Carbolines)IBA 01/2014
1	Sincalide FDA Link 01/2014
1	apatinibIBA 01/2014
1	DH332IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	AlkaloidsIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014
1	CaspasesIBA 01/2014
1	Tobacco Smoke Pollution (Passive Smoking)IBA 05/2013
1	LipidsIBA 03/2013
1	lipoxin A4IBA 03/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2013
1	Hormones (Hormone)IBA 02/2013

Therapy/Procedure

8	Therapeutics 04/2021 - 01/2014
3	Drug Therapy (Chemotherapy) 09/2019 - 01/2019
1	Deep Brain Stimulation 06/2022
1	Treatment Delay 01/2022
1	Lasers (Laser) 01/2021
1	Photothermal Therapy 01/2021
1	Phototherapy (Light Therapy) 01/2021